University of Dundee

CLS Impact and Outreach

£13.6 million award to establish new Wellcome Centre for Anti-Infectives Research in SLS

The University of Dundee has been awarded £13.6 million by Wellcome to establish a new research centre to tackle some of the world’s most devastating diseases.

The Wellcome Centre for Anti-Infectives Research (CAIR) builds on world-leading work at the University’s School of Life Sciences to find new drugs to treat neglected tropical diseases such as malaria, tuberculosis and leishmaniasis.

Cosmic research from compost worm goes on display

A new winter season at Mills Observatory will begin with an interactive project demonstrating how the ‘C. elegans’, a minuscule worm that lives in your compost, helps world-leading research carried out at the University of Dundee.

A massive interactive video wall will allow visitors to get up close and personal with the inner world of the 1mm long roundworm, some of whom have been used by NASA and other space agencies to test the effects of space on aging and the effects of weightlessness.

Professor David Lilley follows in the footsteps of Einstein and Marie Curie by attending the prestigious Solvay Conference.

Last month Professor David Lilley from the School of Life Sciences was selected to chair a session at the prestigious Solvay Conference in Brussels. The Solvay Conferences began in 1911 and take place every three years in physics or chemistry. The event is invitation-only and attended by around 50 scientists who are the world leaders in the area of the meeting. The 1911 Solvay Conference in Physics was the first international conference in physics ever to be organised.

'Molecular commando' identified to tackle hypoxia pathway

Scientists at the University of Dundee have identified a `molecular commando’ which can be stealthily deployed to activate a hypoxic response, a process which can help to fight a range of conditions including stroke, angina, colitis and brain injuries.

A Dundee team led by Professor Alessio Ciulli have used pioneering techniques to develop a `small molecule’ chemical probe called VH298, which offers highly targeted access to the parts of the cell which regulate hypoxia, known as the hypoxic signalling pathway.

Newly discovered protein may hold key to better drugs for neglected diseases

A newly identified method of activating drugs to combat one of the world’s most destructive `neglected’ diseases could lead to better medicines according to new research led by the University of Dundee.

Visceral leishmaniasis (VL) is a disease which blights the developing world with 200,000 to 400,000 new cases and an estimated 40,000 deaths annually, making it the second biggest parasitic killer after malaria. The vast majority of cases are seen in seven countries - India, Nepal, Bangladesh, Brazil, Ethiopia, South Sudan and Sudan.

Pages